Clinical trial
Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD
NCT00363298 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00363298 |
|---|---|
| Title | Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD |
| Official title | Double-blind Trial of Acute and Intermediate-term Dextro-amphetamine Versus Caffeine Augmentation in Treatment Resistant Obsessive Compulsive Disorder (OCD) |
| Lead sponsor | Stanford University, Other |
| Collaborators | Obsessive Compulsive Foundation |
| Status | Completed |
| Study type | Interventional |
| Conditions | Obsessive-Compulsive Disorder |
| Intervention type | Drug |
| Interventions | dextro-amphetamine, Sham Comparison |
| Enrollment | 24 |
| Start date | Aug 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Aug 15, 2006 |
| Last update posted | Mar 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: